- Allison Snoddy | June 27, 2007 12:48 PM |
Category:
MiscellaneousKugel Mesh was developed to treat ventral hernias, which are caused by a stretching or thinning of scar tissue that forms after abdominal surgery. Due to numerous complaints of uncomfortable side effects such as persistent abdominal pain, tenderness near the implant site, fever, nausea and vomiting, the bard composite Kugel mesh patch products have been pulled from the market since...
- Allison Snoddy | June 27, 2007 12:47 PM |
Category:
MiscellaneousNew studies show that women who are pregnant or who might become pregnant should not take the antidepressant Paxil due to birth defects. Nearly a year ago, the U.S. Food and Drug Administration (FDA) and GlaxoSmithKline -- which make Paxil -- changed the warnings on the drug to include the results of the studies.The FDA now advises pregnant women to merely switch from Paxil to another SSRI drug,...
- Allison Snoddy | June 27, 2007 12:46 PM |
Category:
Miscellaneous8 years ago Avandia, a drug used to treat type two diabetes, came onto the market and is now used by over six million people. Experts now caution all users of Avandia to talk to their doctors about whether or not they should be on the drug and are warned not to quit the drug all together because some side effects might occur.According to a review published by the New England Journal of Medicine,...
- Robert Binstock | June 27, 2007 10:33 AM |
Category:
MiscellaneousPredictions made by industry analysts are answering this question with a big yes. Avandia has been associated with causing an increase in the risks of heart attacks. The market for diabetes drugs is extremely competitive, so Avandia has its' hands full. The market could exceed an astounding $30 billion by the year 2011, according to reports. The drug Actos (same class as Avandia) has benefited a...
- Allison Snoddy | June 26, 2007 4:16 PM |
Category:
FDA & Prescription DrugsPaxil is a prescription drug approved to treat depression, general anxiety disorder, social anxiety, obsessive-compulsive disorder, and post traumatic stress disorder. Although the FDA approved Paxil in 1993, there are many side effects that users should be aware of. Studies show that nearly twenty percent of all clinical trial patients in Paxil studies have had to discontinue treatment because...
- Robert Binstock | June 26, 2007 11:13 AM |
Category:
Wrongful DeathShae Conlin took Paxil for two months before she knew she was pregnant. Her daughter only lived for one hour before passing away. She had been taking Paxil for anxiety as well as the birth control pill at the time, so her pregnancy seemed to surprise her. She stopped taking the drug as soon as she found out. She was supposed to have twins and was told that only one baby had a heartbeat. After...
- Robert Binstock | June 26, 2007 9:07 AM |
Category:
MiscellaneousDavol Inc., maker of the Bard Composix Kugel Mesh Patch, was issued a warning letter in 2006 from the FDA about serious problems the product has. The FDA mentioned that these problems needed to be taken care of or there would be consequences. The warning was issued because of numerous cases involving the Kugel Mesh Patch that needed to be addressed. Deaths had been reported although there is no...
- Robert Binstock | June 26, 2007 9:01 AM |
Category:
MiscellaneousMany patients who have been taking Avandia for years are now stopping because of the risks involved with taking the drug. After finding out that a recent study said that Avandia increases heart attack by 43%, many patients have consulted their doctors for advice. All patients of Dr. Dan Allen are no longer taking Avandia. Most have started taking Actos, which is considered to be in the same drug...
- Robert Binstock | June 25, 2007 9:37 AM |
Category:
Defective & Dangerous ProductsPatients should review the latest information to see if they have been implanted with the recalled device and seek medical attention right away if symptoms occur. Patients who have received one of the recalled hernia mesh patches may also qualify for medical monitoring and compensation from the manufacturer. Accurate testing of the Kugel Mesh Patch would have shown the defects of the device and...
- Robert Binstock | June 25, 2007 9:02 AM |
Category:
MiscellaneousBecause of possible increased heart attack in taking the drug Avandia, some doctors are now starting to take patients off the drug. Some doctors are taking patients off Avandia, but replacing it with another drug. GlaxoSmithKline indicates that there are more accurate, longer-term studies that show no significant increased risk. It is hard to take a chance on something like a heart attack...
- Robert Binstock | June 22, 2007 10:11 AM |
Category:
MiscellaneousPrescribers of rosiglitazone (marketed by Avandia) were reminded by the Ministry of Health to not disregard the restrictions for use of the drug in patients with cardiovascular disease.Patients were advised to not stop taking rosiglitazone. Concerns over increased risk of myocardial infarction and cardiovascular death in patients with Type Two diabetes treated with Avandia is more imminent more...
- Robert Binstock | June 21, 2007 9:50 AM |
Category:
Wrongful DeathThe widow and son of a Beaumont man are suing the maker of the popular diabetes drug Avandia, claiming it contributed to the man's death from a heart attack. This man died the same day a scientific analysis was published in the New England Journal of Medicine about more severe risks involved with taking Avandia, such as heart attacks and even death. He had been taking a form of Avandia called...
- Robert Binstock | June 20, 2007 12:51 PM |
Category:
MiscellaneousManaging depression and bipolar disease is not easy to say the least. Researchers looked at whether there was a benefit to adding either Wellbutrin or Paxil for people who are already taking a mood stabilizer. The depression did not go away with the addition of an antidepressant. Manic-depression or bipolar illness is a mood disorder. The manic state comprises grandiosity, hyperactivity,...
- Robert Binstock | June 20, 2007 10:51 AM |
Category:
MiscellaneousThere is currently tons of money being spent on pharmaceutical drugs and most of it seems to be unnecessary. In 2000, pharmaceutical companies spent $2.5 billion on advertising, according to Mike Fillon in "Ephedra: Fact or Fiction." Dr. John Abramson, author of "Overdosed America," says that number increased to more than $3 billion in 2003. The FDA is said to not be able to protect consumers...
- Robert Binstock | June 20, 2007 9:54 AM |
Category:
FDA & Prescription DrugsThe FDA has been criticizing the handling of Avandia for the past three weeks now. Avandia was the subject of a meta-analysis, which is an overview of the results of many smaller studies. In the study, it was found that those taking Avandia had a 43% greater chance of death or heart attack than those not taking the drug. The data was being reviewed and the reputations of Glaxo and the FDA was...
- Robert Binstock | June 19, 2007 10:37 AM |
Category:
MiscellaneousAdvances in medical care over the last three decades have reduced heart disease and extended lives but not for women with diabetes. For men and non-diabetic women, death rates from 1971 to 2000 dropped significantly, but no decline was seen for women with diabetes, a new analysis of federal data finds.It was found that heart disease for everyone, but women with diabetes, steadily declined. The...
- Robert Binstock | June 18, 2007 1:44 PM |
Category:
MiscellaneousA $64 million class action settlement recently approved by an Illinois judge means parents who bought their kids the antidepressant drug Paxil could be eligible to recoup their out-of-pocket expenses.Paxil is said to have misled people about the medication's safety. Parents of children who have taken the drug are trying to get reimbursements under a $64 million class-action deal. Although the...
- Robert Binstock | June 18, 2007 11:56 AM |
Category:
MiscellaneousApril 3, 2006 -- The US Food and Drug Administration (FDA) and Davol, Inc. have notified healthcare professionals regarding the expansion of a class 1 recall for a ventral hernia repair device to include all lots of the oval "midline" size, and lots manufactured before 2004 of the large oval and large circle products. The recall previously affected only the extra-large oval patch.The recall is...
- Robert Binstock | June 18, 2007 10:04 AM |
Category:
MiscellaneousThe current controversy swirling around the diabetes drug Avandia is reminiscent of a similar controversy that arose more than 30 years ago. Then, as now, a study showed that a popular diabetes drug might be causing heart problems instead of preventing them.Back then, many doctors found it hard to believe that a prescribed drug used to lower blood sugar could cause cardiac problems. Scientists...
- Allison Snoddy | June 06, 2007 3:06 PM |
Category:
MiscellaneousOn June 5th 2007, a judge who threw out a $51 million damage award against Merck & Co. last year over its Vioxx painkiller reversed himself. He reversed his decision and awarded $1.6 million ($600,000 in compensatory and 1 million punitive) to a former FBI agent who blamed his heart attack on the drug.Judge Eldon Fallon said that Gerald Barnett could accept the $1.6 million or have a new...
- Vickye Young | June 01, 2007 4:03 PM |
Category:
FDA & Prescription DrugsOn May 21, 2007,the FDA issued a safety alert about Avandia (rosiglitazone maleate) after a study in the New England Journal of Medicine linked the popular diabetes drug to a 43% increase in the risk of heart attack and a 64% increase in the risk of death from all cardiovascular causes. Avandia has become a blockbuster drug for GlaxoSmithKline; since Avandia's launch, over 6 million Americans...
- Lindsay Bauer | June 01, 2007 2:30 PM |
Category:
MiscellaneousAvandia has now joined the ever growing list of drugs not as safe as the FDA first thought. Users of the drug are being urged to see their doctor as soon as possible. Avandia is manufactured by GlaxoSmithKline and is used to treat diabetes. It is now being said that users of Avandia are at an increased risk for heard disease and related problems. The New England Journal of Medicine concluded...